Phase 3 clinical trials run on average 30 percent long than planned, a new study from Cutting Edge Information reports.

On average, the trials take an additional six months, but many delays are “repairable”, Cutting Edge says in”Accelerating Clinical Trials: Budgets, Patient Recruitment and Productivity”. Changes can especially be made in patient recruitment.

Fro details, see: